$ANAB
Anaptysbio, Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
ANAB chart
What traders are saying about $ANAB
Latest postsAnaptysbio, Inc news
- AnaptysBio (ANAB) Gains From Jemperli Approval, Is The Royalty Upside Already Priced In?
Simply Wall Street ·
- AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?
Yahoo Finance ·
- AnaptysBio (ANAB) Expected to Announce Earnings on Tuesday
MarketBeat ·
- AnaptysBio (ANAB) Ticks Up 1.31% to $48.73, Holding Above $46.29 Support - Volume Spike Alerts
www.dars.gov.et ·
- AnaptysBio, Inc. Estimates – FWB:AN6
TradingView ·
- Leerink Partners Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $81
Moomoo ·
- AnaptysBio (NASDAQ:ANAB) Stock Price Up 5.4% - What's Next?
MarketBeat ·
- AnaptysBio Shares Fall 7.74% During GSK-Tesaro Post-Trial Hearing
TOKENPOST ·
- Jemperli FDA Approval Could Expand AnaptysBio Stock Royalty Potential
Simply Wall Street ·
- Jemperli (dostarlimab) Approved in the U.S. as First and Only Immunotherapy for Adults with MSI-H/dMMR Locally Advanced Rectal Cancer
Yahoo Finance ·
- Why This IPO Stock, An AnaptysBio Spinoff, Just Surged
Yahoo Finance ·
- AnaptysBio (ANAB) Could Be 49% Undervalued On Its Royalty Story
Yahoo Finance ·
Anaptysbio, Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $234.6M | $91.3M | $17.2M | $10.3M |
| Net income | -$13.2M | -$145.2M | -$163.6M | -$128.7M |
| Diluted EPS | $-0.44 | $-4.92 | $-6.08 | $-4.57 |
| Total assets (year end) | $364.4M | $483.8M | $452.4M | $610.4M |
| Cash and equivalents (year end) | $138.2M | $23.1M | $36.0M | $71.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Anaptysbio, Inc
- Ticker
- ANAB (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- June 30
- SEC CIK
- 1370053
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
Frequently asked questions
What exchange is Anaptysbio, Inc listed on?
Anaptysbio, Inc trades on the Nasdaq under the ticker symbol ANAB.
What industry is Anaptysbio, Inc in?
Anaptysbio, Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Anaptysbio, Inc headquartered?
Anaptysbio, Inc's business address on file with the SEC is in San Diego, CA.
When does Anaptysbio, Inc's fiscal year end?
Anaptysbio, Inc's fiscal year ends on June 30.
How much revenue did Anaptysbio, Inc report?
Anaptysbio, Inc reported $234.6M in revenue for calendar year 2025, according to its SEC filings.